Administered by:
Effect of recombinant erythropoietin after moderate-to-severe traumatic brain injury:
use of EPO vs placebo in patients with #TBI treated in #ICU did not improve overall very long-term outcomes or QoL, but uncertainty remains, as limited sample size makes it difficult to make the final conclusions: further studies are needed.
Free to read #FOAMcc on @ICM 
https://rdcu.be/dgjia
